Exothera Leads the Charge in High-Density Viral Vector Production
Our teams leverage DoE, AI, and wet lab experiments to tailor the production process and analytics to the needs of our customers, discussed Cédric Volanti, CEO, Exothera in an exclusive interview with Aishwarya Saxena, Pharma Industrial India.
ICellis Bioreactors | 24/10/2024
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy